BioAge Labs

IPO

BioAge Labs is an artificial intelligence company in San Francisco Bay Area, United States, founded in 2015. It has raised $170.0M across 1 round, most recently a $170.0M Series D in February 2024.

Harnessing aging to transform health

Employees
51–200
Founded
2015
Business Model
Other
Total Funding
$170.0M
Last Round
$170.0M Series DFeb 2024
Rounds
1
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 2 investors for this company. The full record is or through the API.

About

BioAge Labs harnesses the biology of human aging to develop therapies for metabolic diseases like obesity and cardiovascular issues. Their pipeline features BGE-102, an NLRP3 inhibitor for inflammation, and an APJ agonist mimicking exercise effects, discovered via a human-first multi-omics platform.

Summary

It lists 51–200 employees. It has raised $170.0M in total across 1 round, most recently a $170.0M Series D round in Feb 2024. Investors include Sofinnova Investments and Andreessen Horowitz.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Data from Indexed.vcUpdated
IPOSep 2024

Sign up to see all 2 events

Funding: Series D. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Devoted Health

Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...

Waltham, United States1001–5000Artificial Intelligence, Healthcare
Series G+Total funding$3.5BOct 2026
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Verily Life Sciences

Verily builds AI-native precision health platforms that help healthcare organizations harmonize d...

Dallas, United States1001–5000Artificial Intelligence, Healthcare
Corporate RoundTotal funding$3.0BMar 2026
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

BioAge Labs on Indexed.vc
<a href="https://indexed.vc/companies/bioage-labs"><img src="https://indexed.vc/api/badge/company/bioage-labs" alt="BioAge Labs on Indexed.vc" width="260" height="76" /></a>